Madrigal Pharmaceuticals
MDGL
MDGL
109 hedge funds and large institutions have $741M invested in Madrigal Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 25
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
81% less call options, than puts
Call options by funds: $1.71M | Put options by funds: $9.11M
Holders
109
Holding in Top 10
1
Calls
$1.71M
Puts
$9.11M
Top Buyers
1 | +$22M | |
2 | +$21M | |
3 | +$5.27M | |
4 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.95M |
5 |
AC
Armistice Capital
New York
|
+$3.74M |
Top Sellers
1 | -$12.4M | |
2 | -$11.2M | |
3 | -$6.83M | |
4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.56M |
5 |
ECM
Element Capital Management
New York
|
-$5.04M |